Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Private Placement
Initial Public Offering Including Over Allotment Option [Member]
Common Class A
Common Class B
Ordinary shares
Ordinary shares
Common Class A
Ordinary shares
Common Class A
Restricted Stock Units (RSUs)
Ordinary shares
Common Class A
Private Placement
Ordinary shares
Common Class A
Initial Public Offering Including Over Allotment Option [Member]
Ordinary shares
Common Class B
Treasury shares at cost
Additional paid-in capital
Additional paid-in capital
Restricted Stock Units (RSUs)
Additional paid-in capital
Private Placement
Additional paid-in capital
Initial Public Offering Including Over Allotment Option [Member]
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019           119,074,382                        
Beginning balance at Dec. 31, 2019 $ (127,292)         $ 12                     $ (988) $ (126,316)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Vesting of restricted shares (Note 18) 0                                  
Vesting of restricted shares (Note 18) (in shares)           2,805,556                        
Share-based compensation expense (Note 18) 8,521                       $ 8,521          
Conversion of ordinary shares to Class A and Class B Ordinary Shares (in shares)           (121,879,938) 45,700,000       76,179,938              
Conversion of ordinary shares to Class A and Class B Ordinary Shares 0         $ (12) $ 4       $ 8              
Accretion on convertible redeemable preferred shares to redemption value (Note 16) (193,465)                       (158,949)         (34,516)
Conversion of convertible redeemable preferred shares to Class A ordinary shares (Note 17) (in shares)             182,917,991                      
Conversion of convertible redeemable preferred shares to Class A ordinary shares (Note 17) 483,436           $ 18           483,418          
Issuance of Class A ordinary shares (in shares)                 22,000,000 80,500,000                
Issuance of Class A ordinary shares   $ 110,000 $ 373,638           $ 2 $ 8         $ 109,998 $ 373,630    
Net (loss) income (3,115)                                 (3,115)
Foreign currency translation adjustments 2,929                               2,929  
Shares issued as part of an acquisition (in shares)             84,634                      
Shares issued as part of an acquisition (Note 3) $ 850                       850          
Exercise of options (in shares) 7,632,431           7,632,431                      
Exercise of options $ 961           $ 1           960          
Ending balance (in shares) at Dec. 31, 2020             338,835,056       76,179,938              
Ending balance at Dec. 31, 2020 656,463           $ 33       $ 8   818,428       1,941 (163,947)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Vesting of restricted shares (Note 18) 78                         $ 78        
Vesting of restricted shares (Note 18) (in shares)               384,585                    
Share-based compensation expense (Note 18) 25,645                       25,645          
Accretion on convertible redeemable preferred shares to redemption value (Note 16) 0                                  
Issuance of Class A ordinary shares (in shares)                 20,000,000                  
Issuance of Class A ordinary shares   $ 249,950             $ 2           $ 249,948      
Net (loss) income (72,355)                                 (72,355)
Foreign currency translation adjustments 1,307                               1,307  
Settlement of VPP (Note 18) 3,512                       3,512          
Unrealized gain on debt securities $ (99)                               (99)  
Exercise of options (in shares) 14,235,844           14,235,844                      
Exercise of options $ 1,760           $ 2           1,758          
Ending balance (in shares) at Dec. 31, 2021 449,635,423     373,455,485 76,179,938   373,455,485       76,179,938 (0)            
Ending balance at Dec. 31, 2021 $ 866,261           $ 37       $ 8   1,099,369       3,149 (236,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Share-based compensation expense (Note 18) 27,851                       27,851          
Accretion on convertible redeemable preferred shares to redemption value (Note 16) 0                                  
Net (loss) income (120,380)                                 (120,380)
Foreign currency translation adjustments (9,857)                               (9,857)  
Settlement of VPP (Note 18) 5,727                       5,727          
Share repurchase (Note 17) (in shares)                       (35,839,004)            
Share repurchase (Note 17) (41,815)                     $ (41,815)            
Unrealized gain on debt securities $ (1,286)                               (1,286)  
Exercise of options (in shares) 10,511,776           10,511,776                      
Exercise of options $ 858           $ 1           857          
Settlement of bonus liability with immediately vested RSUs (in shares)             2,330,328                      
Settlement of bonus liability with immediately vested RSUs $ 901           $ 1           900          
Ending balance (in shares) at Dec. 31, 2022 462,477,527     386,297,589 76,179,938   386,297,589       76,179,938 (35,839,004)            
Ending balance at Dec. 31, 2022 $ 728,260           $ 39       $ 8 $ (41,815) $ 1,134,704       $ (7,994) $ (356,682)